Hemodynamic and hormonal actions of adrenomedullin

Brazilian Journal of Medical and Biological Research

Volumn 37, Issue 8, 2004, Pages 1247-1253

  Nicholls, M Gary ^a  

^a UNITED ARAB EMIRATES UNIVERSITY   (United Arab Emirates)

Author keywords

Adrenomedullin; Aldosterone; Heart failure; Hypertension; Norepinephrine; Renin

Indexed keywords

ADRENOMEDULLIN; ADRENOMEDULLIN RECEPTOR; ALDOSTERONE; ANGIOTENSIN; NORADRENALIN;

ADRENERGIC STIMULATION; ANTIHYPERTENSIVE ACTIVITY; ARTERIAL PRESSURE; ARTICLE; BODY FLUID; BONE DEVELOPMENT; DOSE RESPONSE; DRUG MECHANISM; ELECTROLYTE BALANCE; FLUID BALANCE; HEART DEVELOPMENT; HEART FAILURE; HEART INFARCTION; HEART INJURY; HEART OUTPUT; HEART PROTECTION; HEART RATE; HEART VENTRICLE OVERLOAD; HOMEOSTASIS; HUMAN; HYPERTENSION; INFECTION PREVENTION; NONHUMAN; PATHOPHYSIOLOGY; PROTEIN BLOOD LEVEL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM;

EID: 4444333898     PISSN: 0100879X     EISSN: 1414431X     Source Type: Journal    
DOI: 10.1590/S0100-879X2004000800016     Document Type: Article

References (34)

1. Kitamura K, Kangawa K, Kawamoto M, Ichiki Y, Nakamura S, Matsuo H & Eto T (1993). Adrenomedullin: a novel hypotensive peptide isolated from human pheochromocytoma. Biochemical and Biophysical Research Communications, 192: 553-560.
2. Lainchbury JG, Cooper GJS, Coy DH, Jiang NY, Lewis LK, Yandle TG, Richards AM & Nicholls MG (1997). Adrenomedullin: a hypotensive hormone in man. Clinical Science, 92: 467-472.
3. Cockcroft JR, Noon JP, Gardner-Medwin J & Bennett T (1997). Haemodynamic effects of adrenomedullin in human resistance and capacitance vessels. British Journal of Clinical Pharmacology, 44: 57-60.
4. Lainchbury JG, Troughton RW, Lewis LK, Yandle TG, Richards AM & Nicholls MG (2000). Hemodynamic, hormonal, and renal effects of short-term adrenomedullin infusion in healthy volunteers. Journal of Clinical Endocrinology and Metabolism, 85: 1016-1020.
5. Del Bene R, Lazzeri C, Barletta G, Vecchiarino S, Guerra CT, Franchi F & La Villa G (2000). Effects of low-dose adrenomedullin on cardiac function and systemic haemodynamics in man. Clinical Physiology, 20: 457-465.
6. Charles CJ, Rademaker MT, Richards AM, Cooper GJS, Coy DH, Jing NY & Nicholls MG (1997). Hemodynamic, hormonal, and renal effects of adrenomedullin in conscious sheep. American Journal of Physiology, 272: R2040-R2047.
7. Yamaguchi T, Baba K, Doi Y & Yano K (1995). Effect of adrenomedullin on aldosterone secretion by dispersed rat adrenal zona glomerulosa cells. Life Sciences, 56: 379-387.
8. Andreis PG, Mazzocchi G, Rebuffat P & Nussdorfer GG (1997). Effects of adrenomedullin and proadrenomedullin N-terminal 20 peptide on rat zona glomerulosa cells. Life Sciences, 60: 1693-1697.
9. Meeran K, O'Shea D, Upton PD, Small CJ, Ghatei MA, Byfield PH & Bloom SR (1997). Circulating adrenomedullin does not regulate systemic blood pressure but increases plasma prolactin after intravenous infusion in humans: a pharmacokinetic study. Journal of Clinical Endocrinology and Metabolism, 82: 95-100.
10. Petrie MC, Hillier C, Morton JJ & McMurray JJ (2000). Adrenomedullin selectively inhibits angiotensin II-induced aldosterone secretion in humans. Journal of Hypertension, 18: 61-64.
11. Troughton RW, Frampton CM, Lewis LK, Yandle TG, Richards AM & Nicholls MG (2001). Differing thresholds for modulatory effects of adrenomedullin infusion on haemodynamic and hormone responses to angiotensin II and adrenocorticotrophic hormone in healthy volunteers. Clinical Science, 101: 103-109.
12. Charles CJ, Rademaker MT, Richards AM, Cooper GJ, Coy DH & Nicholls MG (2000). Adrenomedullin attenuates pressor response to angiotensin II in conscious sheep. Journal of Cardiovascular Pharmacology, 36: 526-532.
13. Charles CJ, Nicholls MG, Rademaker MT & Richards AM (2001). Comparative actions of adrenomedullin and nitroprusside: interactions with ANG II and norepinephrine. American Journal of Physiology, 281: R1887-R1894.
14. Luodonpaa M, Leskinen H, Ilves M, Vuolteenaho O & Ruskoaho H (2004). Adrenomedullin modulates hemodynamic and cardiac effects of angiotensin II in conscious rats. American Journal of Physiology (in press).
15. Troughton RW, Lewis LK, Yandle TG, Richards AM & Nicholls MG (2000). Hemodynamic, hormone, and urinary effects of adrenomedullin infusion in essential hypertension. Hypertension, 36: 588-593.
16. Khan AI, Kato J, Ishiyama Y, Kitamura K, Kangawa K & Eto T (1997). Effect of chronically infused adrenomedullin in two-kidney, one-clip hypertensive rats. European Journal of Pharmacology, 333: 187-190.
17. Khan AI, Kato J, Kitamura K, Kangawa K & Eto T (1997). Hypotensive effect of chronically infused adrenomedullin in conscious Wistar-Kyoto and spontaneously hypertensive rats. Clinical and Experimental Pharmacology and Physiology, 24: 139-142.
18. Tian Q, Zhao D, Tan DY et al. (1995). Vasodilator effect of human adrenomedullin(13-52) on hypertensive rats. Canadian Journal of Physiology and Pharmacology, 73: 1065-1069.
19. Rademaker MT, Cameron VA, Charles CJ, Lainchbury JG, Nicholls MG & Richards AM (2003). Adrenomedullin and heart failure. Regulatory Peptides, 112: 51-60.
20. Lainchbury JG, Nicholls MG, Espiner EA, Yandle TG, Lewis LK & Richards AM (1999). Bioactivity and interactions of adrenomedullin and brain natriuretic peptide in patients with heart failure. Hypertension, 34: 70-75.
21. Nagaya N, Satoh T, Nishikimi T et al. (2000). Hemodynamic, renal, and hormonal effects of adrenomedullin infusion in patients with congestive heart failure. Circulation, 101: 498-503.
22. Oya H, Nagaya N, Furuichi S, Nishikimi T, Ueno K, Nakanishi N, Yamagishi M, Kangawa K & Miyatake K (2000). Comparison of intravenous adrenomedullin with atrial natriuretic peptide in patients with congestive heart failure. American Journal of Cardiology, 86: 94-98.
23. Nakamura M, Yoshida H, Makita S, Arakawa N, Niinuma H & Hiramon K (1997). Potent and long-lasting vasodilatory effects of adrenomedullin in humans. Comparisons between normal subjects and patients with chronic heart failure. Circulation, 95: 1214-1221.
24. Nishikimi T, Yoshihara F, Mori Y, Kangawa K & Matsuoka H (2003). Cardioprotective effect of adrenomedullin in heart failure. Hypertension Research, 26 (Suppl): S121-S127.
25. Hinson JP, Kapas S & Smith DM (2000). Adrenomedullin, a multifunctional regulatory peptide. Endocrine Reviews, 21: 138-167.
26. McGregor DO, Troughton RW, Frampton C, Lynn KL, Yandle T, Richards AM & Nicholls MG (2001). Hypotensive and natriuretic actions of adrenomedullin in subjects with chronic renal impairment. Hypertension, 37: 1279-1284.
27. Nagaya N, Nishikimi T, Uematsu M et al. (2000). Haemodynamic and hormonal effects of adrenomedullin in patients with pulmonary hypertension. Heart, 84: 653-658.
28. Kandler MA, Von Der Hardt K, Mahfoud S, Chada M, Schoof E, Papadopoulos T, Rascher W & Dotsch J (2003). Pilot intervention: aerosolized adrenomedullin reduces pulmonary hypertension. Journal of Pharmacology and Experimental Therapeutics, 306: 1021-1026.
29. Nagaya N, Kyotani S, Uematsu M, Ueno K, Oya H, Nakanishi N, Shirai M, Mori H, Miyatake K & Kangawa K (2004). Effects of adrenomedullin inhalation on hemodynamics and exercise capacity in patients with idiopathic pulmonary arterial hypertension. Circulation, 109: 351-356.
30. Kato K, Yin H, Agata J, Yoshida H, Chao L & Chao J (2003). Adrenomedullin gene delivery attenuates myocardial infarction and apoptosis after ischemia and reperfusion. American Journal of Physiology, 285: H1506-H1514.
31. Nishikimi T, Yoshihara F, Horinaka S, Kobayashi N, Mori Y, Tadokoro K, Akimoto K, Minamino N, Kangawa K & Matsuoka H (2003). Chronic administration of adrenomedullin attenuates transition from left ventricular hypertrophy to heart failure in rats. Hypertension, 42: 1034-1041.
32. Kawai J, Ando K, Tojo A, Shimosawa T, Takahashi K, Onozato ML, Yamasaki M, Ogita T, Nakaoka T & Fujita T (2004). Endogenous adrenomedullin protects against vascular response to injury in mice. Circulation, 109: 1147-1153.
33. Rademaker MT, Charles CJ, Cooper GJ, Coy DH, Espiner EA, Lewis LK, Nicholls MG & Richards AM (2002). Combined angiotensin-converting enzyme inhibition and adrenomedullin in an ovine model of heart failure. Clinical Science, 102: 653-660.
34. Rademaker MT, Charles CJ, Cooper GJS, Coy DH, Espiner EA, Lewis LK, Nicholls MG & Richards AM (2002). Combined endopeptidase inhibition and adrenomedullin in sheep with experimental heart failure. Hypertension, 39: 93-98.